CN Patent

CN116456968B — 生长抑素调节剂的制剂

Assigned to Crinetics Pharmaceuticals Inc · Expires 2026-03-20 · 0y expired

What this patent protects

一种喷雾干燥的固体分散体,所述喷雾干燥的固体分散体包含:(a)3‑[4‑(4‑氨基‑哌啶‑1‑基)‑3‑(3,5‑二氟‑苯基)‑喹啉‑6‑基]‑2‑羟基‑苄腈或其药学上可接受的盐或溶剂化物;和(b)药学上可接受的聚合物;其中所述API分散在由所述药学上可接受的聚合物形成的聚合物基质中。一种片剂,所述片剂包含所述喷雾干燥的固体分散体和选自一种或多种稀释剂、一种或多种崩解剂、一种或多种润滑剂、一种或多种助流剂的一种或多种药学上可接受的成分。所述片剂通过口服施用而用于治疗人的肢端肥大症或神经内分泌肿瘤或两者。

USPTO Abstract

一种喷雾干燥的固体分散体,所述喷雾干燥的固体分散体包含:(a)3‑[4‑(4‑氨基‑哌啶‑1‑基)‑3‑(3,5‑二氟‑苯基)‑喹啉‑6‑基]‑2‑羟基‑苄腈或其药学上可接受的盐或溶剂化物;和(b)药学上可接受的聚合物;其中所述API分散在由所述药学上可接受的聚合物形成的聚合物基质中。一种片剂,所述片剂包含所述喷雾干燥的固体分散体和选自一种或多种稀释剂、一种或多种崩解剂、一种或多种润滑剂、一种或多种助流剂的一种或多种药学上可接受的成分。所述片剂通过口服施用而用于治疗人的肢端肥大症或神经内分泌肿瘤或两者。

Drugs covered by this patent

Patent Metadata

Patent number
CN116456968B
Jurisdiction
CN
Classification
Expires
2026-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Crinetics Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.